Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

Foghorn Therapeutics Inc (FHTX)

  • Technical Exchange News
  • Jan. 28, 2024, 23:21 UTC
  • 32
  • 0 comments

NASDAQ traded attribute type Security_Name was changed. Previous value: -. New value: Foghorn Therapeutics Inc. - Common Stock.

Comment Full text

Fennec Pharmaceuticals Inc (FENC)

  • Technical Exchange News
  • Jan. 28, 2024, 23:21 UTC
  • 31
  • 0 comments

NASDAQ traded attribute type Test_mode was changed. Previous value: -. New value: N.

Comment Full text

Fennec Pharmaceuticals Inc (FENC)

  • Technical Exchange News
  • Jan. 28, 2024, 23:21 UTC
  • 31
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: -. New value: N.

Comment Full text

Fennec Pharmaceuticals Inc (FENC)

  • Technical Exchange News
  • Jan. 28, 2024, 23:21 UTC
  • 31
  • 0 comments

NASDAQ traded attribute type Security_Name was changed. Previous value: -. New value: Fennec Pharmaceuticals Inc. - Common Stock.

Comment Full text

Femasys Inc (FEMY)

  • Technical Exchange News
  • Jan. 28, 2024, 23:21 UTC
  • 32
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: -. New value: N.

Comment Full text

Femasys Inc (FEMY)

  • Technical Exchange News
  • Jan. 28, 2024, 23:21 UTC
  • 32
  • 0 comments

NASDAQ traded attribute type Security_Name was changed. Previous value: -. New value: Femasys Inc. - Common Stock.

Comment Full text

Femasys Inc (FEMY)

  • Technical Exchange News
  • Jan. 28, 2024, 23:21 UTC
  • 32
  • 0 comments

NASDAQ traded attribute type Test_mode was changed. Previous value: -. New value: N.

Comment Full text

4D Molecular Therapeutics (FDMT)

  • Technical Exchange News
  • Jan. 28, 2024, 23:21 UTC
  • 30
  • 0 comments

NASDAQ traded attribute type Security_Name was changed. Previous value: -. New value: 4D Molecular Therapeutics, Inc. - Common Stock.

Comment Full text

4D Molecular Therapeutics (FDMT)

  • Technical Exchange News
  • Jan. 28, 2024, 23:21 UTC
  • 32
  • 0 comments

NASDAQ traded attribute type Test_mode was changed. Previous value: -. New value: N.

Comment Full text

4D Molecular Therapeutics (FDMT)

  • Technical Exchange News
  • Jan. 28, 2024, 23:21 UTC
  • 31
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: -. New value: N.

Comment Full text
  • Previous
  • 1066
  • 1067
  • 1068
  • 1069
  • 1070
  • Next

Search

News categories

  • Technical Exchange News(12226)
  • Event(6195)
  • SEC News(263975)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(154576)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin